filmov
tv
Former FDA Chief Scott Gottlieb calls for 'massive surveillance system' to prevent future outbreaks
Показать описание
Dr. Scott Gottlieb, member of the boards of Pfizer and biotech company Illumina and former FDA commissioner, joins "Squawk Box" to discuss the latest on fight coronavirus in the U.S. and around the world.
The coronavirus will continue to disrupt daily life in the fall unless there is an effective drug to treat it, former Food and Drug Administration Commissioner Scott Gottlieb said Thursday.
“If we don’t have it, this virus is going to come back in the fall and it’s going to continue to shut down parts of our lives,” Gottlieb said on CNBC’s “Squawk Box.”
“This is going to circulate in the background. The consumer is not going to bounce back. People are going to be afraid to go out and we’re going to continue to see people succumb to this virus,” he added.
Gottlieb said the sense of “urgency” being applied to the development of a COVID-19 vaccine needs to be applied to developing a therapeutic.
“We really need to figure that a vaccine might be two years away,” contended Gottlieb, a CNBC contributor who sits on the boards of Pfizer and biotech company Illumina.
A drug, by contrast, can be developed “in the near term,” Gottlieb said. But he said it will require global regulators to change their approach, much like they have done toward COVID-19 vaccine development.
He pointed to the National Institutes of Health’s work with biotech company Moderna. Together, NIH and Moderna have already begun phase one human trials of a vaccine in the Seattle area.
For more coronavirus live updates:
For access to live and exclusive video from CNBC subscribe to CNBC PRO:
Turn to CNBC TV for the latest stock market news and analysis. From market futures to live price updates CNBC is the leader in business news worldwide.
Connect with CNBC News Online
#CNBC
#CNBC TV
The coronavirus will continue to disrupt daily life in the fall unless there is an effective drug to treat it, former Food and Drug Administration Commissioner Scott Gottlieb said Thursday.
“If we don’t have it, this virus is going to come back in the fall and it’s going to continue to shut down parts of our lives,” Gottlieb said on CNBC’s “Squawk Box.”
“This is going to circulate in the background. The consumer is not going to bounce back. People are going to be afraid to go out and we’re going to continue to see people succumb to this virus,” he added.
Gottlieb said the sense of “urgency” being applied to the development of a COVID-19 vaccine needs to be applied to developing a therapeutic.
“We really need to figure that a vaccine might be two years away,” contended Gottlieb, a CNBC contributor who sits on the boards of Pfizer and biotech company Illumina.
A drug, by contrast, can be developed “in the near term,” Gottlieb said. But he said it will require global regulators to change their approach, much like they have done toward COVID-19 vaccine development.
He pointed to the National Institutes of Health’s work with biotech company Moderna. Together, NIH and Moderna have already begun phase one human trials of a vaccine in the Seattle area.
For more coronavirus live updates:
For access to live and exclusive video from CNBC subscribe to CNBC PRO:
Turn to CNBC TV for the latest stock market news and analysis. From market futures to live price updates CNBC is the leader in business news worldwide.
Connect with CNBC News Online
#CNBC
#CNBC TV
0:04:45
Former FDA chief Scott Gottlieb on Russia's Covid-19 vaccine claims
0:03:26
Former FDA chief Scott Gottlieb on Covid-19 data controversy
0:06:17
Former FDA chief Dr. Scott Gottlieb on U.S. coronavirus hot spots
0:03:22
Former FDA chief Dr. Scott Gottlieb makes the case for vaccine passports
0:12:07
Why The Flu Season Will Be A ‘Whopper’: Former FDA Chief Scott Gottlieb
0:05:02
Coronavirus: There will be a coronavirus therapeutic very soon, Former FDA head Scott Gottlieb says
0:00:37
Former FDA Chief Scott Gottlieb joins Pfizer's board
0:08:24
Former FDA Chief Scott Gottlieb calls for 'massive surveillance system' to prevent future ...
0:03:29
Former FDA chief Scott Gottlieb on the risk of asymptomic Covid-19 cases
0:05:13
Former FDA chief Scott Gottlieb on why the public can trust the vaccine approval process
0:05:57
Former FDA chief Dr. Scott Gottlieb on accuracy of rapid Covid-19 tests
0:03:58
Former FDA chief Scott Gottlieb on how long we'll be wearing masks
0:05:13
Former FDA chief Scott Gottlieb on New Jersey's Covid-19 vaccine rollout and more
0:04:46
Former FDA Chief Scott Gottlieb answers viewer questions on coronavirus
0:05:48
Former FDA chief Scott Gottlieb on coronavirus plasma treatment
0:03:04
Lifting lockdowns won't fully restore the economy: Former FDA chief Scott Gottlieb
0:04:44
Former FDA chief Scott Gottlieb on ethics of human challenge trials for Covid-19 vaccine
0:04:15
Former FDA chief Scott Gottlieb on the current coronavirus outbreak in the White House
0:05:14
Former FDA chief Scott Gottlieb on CDC changing stance on coronavirus guidance
0:05:08
Fmr. FDA chief Dr. Scott Gottlieb discusses potential Covid 'USA variant'
0:06:14
Former FDA chief Scott Gottlieb on coronavirus antibody tests, reopening the economy and more
0:03:57
Former FDA chief Scott Gottlieb: Covid-19 vaccine will likely be a 2021 event
0:01:15
U.K. researchers purposely exposing volunteers to coronavirus: Former FDA chief Scott Gottlieb
0:05:13
Former FDA chief Scott Gottlieb on CDC's back-to-school guidelines
Комментарии